In light of uncertainties surrounding US tariffs on pharmaceuticals, Kotak Institutional Equities noted in a recent report that the most…
Indian pharma stocks: Macquarie Equity Research has initiated outperform ratings for Divi's Labs, Suven Pharma, Bluejet Healthcare, and Syngene. Among…